X0206 3 2013-11-13 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001340660 HLM VENTURE PARTNERS II, L.P. 222 BERKELEY STREET BOSTON MA 02116 0 0 1 0 0001591541 HLM Venture Associates II, LLC 222 BERKELEY STREET BOSTON MA 02116 0 0 1 0 0001025665 CAHILL EDWARD L C/O HLM VENTURE PARTNERS 222 BERKELEY STREET BOSTON MA 02116 1 0 1 0 0001242813 GRUA PETER J C/O HLM VENTURE PARTNERS 222 BERKELEY STREET BOSTON MA 02116 0 0 1 0 0001225960 RAY RUSSELL T C/O HLM VENTURE PARTNERS 222 BERKELEY STREET BOSTON MA 02116 0 0 1 0 Series C Preferred Stock 0.00 Common Stock 223684 D Series D Preferred Stock 0.00 Common Stock 1230374 D Preferred Stock Warrant 4.40 2021-08-17 Series D Preferred Stock 87662 D Preferred Stock Warrant 4.40 2022-05-25 Series D Preferred Stock 21915 D Preferred Stock Warrant 4.40 2022-07-17 Series D Preferred Stock 33014 D The securities are immediately convertible. The expiration date is not relevant to the conversion of these securities. The reported securities are owned by HLM Venture Partners II, L.P. HLM Venture Associates II, L.L.C. (the "General Partner"), and Edward L. Cahill, Peter J. Grua and Russell T. Ray, the managing members of the General Partner, may be deemed to share voting and dispositive power over the reported securities but each disclaims beneficial ownership in the securities held by HLM Venture Partners II, L.P., except to the extent of their pecuniary interest therein. The warrants are immediately exercisable. Upon the consummation of the Issuer's initial public offering, these warrants will automatically become exercisable for 52,316 shares of the Issuer's common stock at an exercise price of $4.40 per share. Upon the consummation of the Issuer's initial public offering, these warrants will automatically become exercisable for 13,078 shares of the Issuer's common stock at an exercise price of $4.40 per share. Upon the consummation of the Issuer's initial public offering, these warrants will automatically become exercisable for 19,702 shares of the Issuer's common stock at an exercise price of $4.40 per share. /s/ David B. Berger, Attorney-in-Fact for HLM Venture Partners II, L.P. 2013-11-13 /s/ David B. Berger, Attorney-in-Fact for HLM Venture Associates II, L.L.C. 2013-11-13 /s/ David B. Berger, Attorney-in-Fact for Edward L. Cahill 2013-11-13 /s/ David B. Berger, Attorney-in-Fact for Peter J. Grua 2013-11-13 /s/ David B. Berger, Attorney-in-Fact for Russell T. Ray 2013-11-13